Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/09/2012WO2012104793A1 An antibacterial and antiviral compound
08/09/2012WO2012104788A2 Anti-angiogenic compounds, pharmaceutical compositions containing same, and use thereof
08/09/2012WO2012104782A1 Pyrrole derivatives used as modulators of alpha7 nachr
08/09/2012WO2012104776A1 Novel heterocyclic derivatives
08/09/2012WO2012104752A1 Pharmaceutical composition comprising opioid agonist and sequestered antagonist
08/09/2012WO2012104730A1 Pharmaceutical preparation
08/09/2012WO2012104728A1 Simplified process to extract quassinoids
08/09/2012WO2012104706A1 New combination for the treatment of pain
08/09/2012WO2012104659A1 Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease
08/09/2012WO2012104655A2 Compostions and methods for treating chronic inflammation and inflammatory diseases
08/09/2012WO2012104654A1 Compositions and methods for treating cardiovascular diseases
08/09/2012WO2012104589A1 Weight related disorders
08/09/2012WO2012104571A1 Compositions of monoterpenoids for the treatment of influenza
08/09/2012WO2012104570A1 Composition of monoterpenoids having bactericidal properties
08/09/2012WO2012104569A1 Composition of monoterpenoids for the treatment of cancer
08/09/2012WO2012104568A1 Compositions of monoterpenoids for stimulating the immune system
08/09/2012WO2012104567A1 Compositions of monoterpenoids for the treatment of an hiv infection
08/09/2012WO2012104538A1 Novel 1,5-dihydropyrrol-2-one derivatives for use in the treatment of malaria or other parasitic and fungal diseases
08/09/2012WO2012104467A1 Use of no synthase (nos) activity inhibitors and compositions thereof in the production of a drug for the treatment and prevention of prediabetes and type 1 diabetes mellitus (dm1)
08/09/2012WO2012104461A1 Development and use of polymer nanoparticles comprising poly(epsilon-caprolactone) and doxorubicin
08/09/2012WO2012104428A1 (5s,8s)-3-(4'-chlor-3'-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one (compound a) for treatment
08/09/2012WO2012104418A2 Method for inactivation/removal of coagulation factors by precipitation
08/09/2012WO2012104402A1 Treatment of severe persitent asthma with masitinib
08/09/2012WO2012104388A1 New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
08/09/2012WO2012104342A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
08/09/2012WO2012104338A1 Spiro aminic compounds with nk1 antagonist activity
08/09/2012WO2012104305A1 Antimicrobial 4-oxoquinolizines
08/09/2012WO2012104293A1 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
08/09/2012WO2012104241A1 Combinations of aromatase inhibitors and antioxidants
08/09/2012WO2012104206A1 9-[4-(3-chlor-2-fluor-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one dimaleate, use thereof as a drug, and production thereof
08/09/2012WO2012104204A1 Iron-carbohydrate complex compounds for the intravenous therapy of malaria
08/09/2012WO2012104139A1 Method of preparation of metaxalone
08/09/2012WO2012103990A1 Phosphoramidates of monosaccharides
08/09/2012WO2012103959A1 Process for making everolimus
08/09/2012WO2012103813A1 Danshensu and chuanxiongqin derivatives, process for preparation, and use thereof
08/09/2012WO2012103810A1 Certain chemical entities, compositions, and methods
08/09/2012WO2012103809A1 Sexual function improving agent
08/09/2012WO2012103807A1 Bifunctional anti-platelet aggregation medicament and uses thereof
08/09/2012WO2012103806A1 Bicyclic heteroaryl compounds as gpr119 receptor agonists
08/09/2012WO2012103784A1 Nitrogen-containing artemisinin dimers, preparation methods and uses thereof
08/09/2012WO2012103783A1 Use of artemisine derivatives and pharmaceutical salts thereof
08/09/2012WO2012103777A1 Compound isolated from monascus purpureus, preparation method therefor and uses thereof
08/09/2012WO2012103692A1 Sexual function improving agent
08/09/2012WO2012103685A1 Sexual function improving agent
08/09/2012WO2012103634A1 Cellulose-based nanoparticles for drug delivery
08/09/2012WO2012103588A1 Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
08/09/2012WO2012103583A1 Positive allosteric modulators of the alpha 7 nicotinic acetylcholine receptor and uses thereof.
08/09/2012WO2012103570A1 Composition comprising b group vitamins or feverfew and treatment of headaches with such compositions
08/09/2012WO2012092528A8 Treatment of erectile dysfunction and other indications
08/09/2012WO2012082841A9 Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer
08/09/2012WO2012078695A9 Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracyclin chemotherapeutic agents
08/09/2012WO2012076916A8 Therapeutic association of 5 - hydroxy - tryptophan and caffeine for the treatment of the symptom of parkinson's disease, daytime sleepiness
08/09/2012WO2012075484A9 Novel drug targets to overcome de novo drug-resistance in multiple myeloma
08/09/2012WO2012071389A3 Stable cannabinoid compositions and methods for making and storing them
08/09/2012WO2012070798A3 Topical antifungal composition comprising terbinafine or its salt
08/09/2012WO2012069836A3 Biologically active complex and its preparation
08/09/2012WO2012064306A3 Effervescent formulations of rosuvastatin
08/09/2012WO2012064305A3 Formulations comprising montelukast and levocetirizine
08/09/2012WO2012064304A3 Combinations comprising montelukast
08/09/2012WO2012058627A3 Pre-targeted nanoparticle system and method for labeling biological particles
08/09/2012WO2012056452A3 Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
08/09/2012WO2012052995A3 Treatment and prevention of hepatocellular carcinoma with chemokine receptor modulators
08/09/2012WO2012051374A3 Use of monoamine oxidase inhibitors to improve epithelial biology
08/09/2012WO2012049677A3 Compositions for treating psoriasis of the scalp
08/09/2012WO2012048294A3 Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
08/09/2012WO2012047587A3 Mdm2 inhibitors for treatment of ocular conditions
08/09/2012WO2012047495A3 Methods for preparing synthetic bile acids and compositions comprising the same
08/09/2012WO2012047265A3 Improved adjuvant system for vaccine administration
08/09/2012WO2012046030A3 Phosphodiesterase inhibitors
08/09/2012WO2012044531A8 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals
08/09/2012WO2012042224A3 Pharmaceutical composition comprising deferasirox
08/09/2012WO2012030309A3 Formulation of comprising tiotropium and a calcium channel blocker
08/09/2012WO2012021788A3 Dipeptide calpain inhibitors
08/09/2012WO2012019113A3 Inhibitors of erk for developmental disorders of neuronal connectivity
08/09/2012WO2012015775A3 Sirna targeting vegfa and methods for treatment in vivo
08/09/2012WO2012004588A3 Therapeutic agents 976
08/09/2012WO2011163452A8 Treating surface of the eye disorders
08/09/2012WO2011159769A3 Indane estrogen receptor modulators and uses thereof
08/09/2012WO2011156451A3 Compositions and methods for modulating toll-like receptor 2 activation
08/09/2012WO2011133964A3 Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
08/09/2012WO2011133790A3 Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain
08/09/2012WO2011087981A3 Clinical benefits of eicosapentaenoic acid in humans
08/09/2012WO2010075549A3 Nucleoside phosphoramidates
08/09/2012US20120204281 Drg11-responsive (dragon) gene family
08/09/2012US20120204280 Drg11-responsive (dragon) gene family
08/09/2012US20120204276 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis
08/09/2012US20120203162 Method for treating neovascularization
08/09/2012US20120203161 Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method of use
08/09/2012US20120203147 Vasodilator-enhanced cardiopulmonary resuscitation
08/09/2012US20120203102 Azulene and azaazulene systems for imaging, monitoring and therapy
08/09/2012US20120203051 Treatment of cancer using the sodium salt of a benzoic acid derivative
08/09/2012US20120202996 Tetrahydroquinoline derivatives
08/09/2012US20120202983 Conjugates and Compositions for Cellular Delivery
08/09/2012US20120202981 Novel guanosine-rich modified oligonucleotides and antiproliferative activity thereof
08/09/2012US20120202892 Cannabinoid-Containing Compositions and Methods for Their Use
08/09/2012US20120202891 Cannabinoid-Containing Compositions and Methods for Their Use
08/09/2012US20120202890 Polymer-carbohydrate-lipid conjugates
08/09/2012US20120202889 Production method for astaxanthin-containing composition
08/09/2012US20120202888 Biomarkers of prostate cancer and predicting mortality
08/09/2012US20120202887 Facially Amphiphilic Polyaryl and Polyarylalkynyl Polymers and Oligomers and Uses Thereof
1 ... 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 ... 7860